Prior to joining Intensity Therapeutics, Inc. Rebecca (Peggi) Drain was Director of Bristol-Myers Squibb’s Oncology Regulatory Submissions group. She was responsible for the operational and technical execution of multiple complex, high visibility Investigational and Marketing application submission strategies including issue mitigation, staff management, resource planning and quality oversight. Peggi led the global application process for the Immuno-Oncology (I-O) portfolio for large and small molecules, including over 80 global investigational and marketing applications resulting in numerous regulatory approvals. She is a regulatory framework subject matter expert with over 25 years of drug development expertise spanning multiple therapeutic areas including neuroscience, anti-infectives and oncology. She also spent several years in the early drug development space at Bristol-Myers Squibb and Protein Sciences, developing anti-infective products and vaccines including those for HIV.
She has a Bachelor of Science in Pathobiology from The University of Connecticut.